Biomarkers prediction and immune landscape in ulcerative colitis: Findings based on bioinformatics and machine learning

Yuanming Yang(Qingdao University), Shaogang Huang(Guangzhou University of Chinese Medicine), Yiwei Hua(Guangzhou University of Chinese Medicine), Zhining Ye(Guangzhou University of Chinese Medicine), Kai Zhan(Guangzhou University of Chinese Medicine), Shumin Qin(Guangzhou University of Chinese Medicine), Yueming Gu(Guangzhou University of Chinese Medicine), Shuhao Qi(Guangzhou University of Chinese Medicine), Jia Rui(Guangzhou University of Chinese Medicine), Haomeng Wu(Guangzhou University of Chinese Medicine), Huan Zheng(Guangzhou University of Chinese Medicine), Guifang Su(Guangzhou University of Chinese Medicine), Kairui Tang(Jinan University)
Computers in Biology and Medicine
December 2, 2023
10.1016/j.compbiomed.2023.107778
Cited by 47

Related Papers

Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity
|The ISME Journal|2021|120
Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
|Frontiers in Public Health|2022|28
Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
|Oxidative Medicine and Cellular Longevity|2020|27
The function of the gut microbiota–bile acid–TGR5 axis in diarrhea-predominant irritable bowel syndrome
|mSystems|2024|25
Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
|Frontiers in Pharmacology|2022|23